Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2011, Article ID 310962, 10 pages
http://dx.doi.org/10.1093/ecam/nep016
Original Article

Aqueous Extract of Shi-Liu-Wei-Liu-Qi-Yin Induces G2/M Phase Arrest and Apoptosis in Human Bladder Carcinoma Cells via Fas and Mitochondrial Pathway

1Institute of Biochemistry and Biotechnology, College of Medicine, Chung Shan Medical University, Taichung, Taiwan
2Department of Nuclear Medicine, Chang Bing, Show-Chwan Memorial Hospital, Changhua, Taiwan
3Department of Anatomy, China Medical University, No. 91, Hsueh-Shih Road, Taichung, Taiwan

Received 23 September 2008; Accepted 28 January 2009

Copyright © 2011 Ting-Tsz Ou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Jiang, H. J. Lee, G. X. Li, J. Guo, B. Malewicz, Y. Zhao et al., “Potent antiandrogen and androgen receptor activities of an Angelica gigas-containing herbal formulation: identification of decursin as a novel and active compound with implications for prevention and treatment of prostate cancer,” Cancer Research, vol. 66, pp. 453–463, 2006. View at Google Scholar
  2. H. H. Lin, H. P. Huang, C. C. Huang, J. H. Chen, and C. J. Wang, “Hibiscus polyphenol-rich extract induces apoptosis in human gastric carcinoma cells via p53 phosphorylation and p38 MAPK/FasL cascade pathway,” Molecular Carcinogenesis, vol. 43, pp. 86–89, 2005. View at Google Scholar
  3. K. Matsuura, T. Kawakita, S. Nakai, Y. Saito, A. Suzuki, and K. Nomoto, “Role of B-lymphocytes in the immunopharmacological effects of a traditional Chinese medicine, Xiao-chai-hu-tang (Shosaiko-to),” International Journal of Immunopharmacology, vol. 15, no. 2, pp. 237–243, 1993. View at Google Scholar
  4. B. Saad, H. Azaizeh, G. Abu-Hijleh, and O. Said, “Safety of traditional Arab herbal medicine,” Evidence-Based Complementary and Alternative Medicine, vol. 3, no. 4, pp. 433–439, 2006. View at Publisher · View at Google Scholar · View at PubMed
  5. H. Kiyohara, T. Matsumoto, and H. Yamada, “Combination effects of herbs in a multi-herbal formula: expression of Juzen-taiho-to's immuno-modulatory activity on the intestinal immune system,” Evidence-Based Complementary and Alternative Medicine, vol. 1, pp. 83–91, 2004. View at Google Scholar
  6. S.-J. Su, T.-M. Yeh, H.-Y. Lei, and N.-H. Chow, “The potential of soybean foods as a chemoprevention approach for human urinary tract cancer,” Clinical Cancer Research, vol. 6, no. 1, pp. 230–236, 2000. View at Google Scholar
  7. C. H. Spruck III, P. F. Ohneseit, M. Gonzalez-Zulueta et al., “Two molecular pathways to transitional cell carcinoma of the bladder,” Cancer Research, vol. 54, no. 3, pp. 784–788, 1994. View at Google Scholar
  8. A. Tyagi, C. Agarwal, G. Harrison, L. M. Glode, and R. Agarwal, “Silibinin causes cell cycle arrest and apoptosis in human bladder transitional cell carclin cascade, and caspase 3 and PARP cleavages,” Carcinogenesis, vol. 25, pp. 1711–1720, 2004. View at Google Scholar
  9. R. Agarwal, “Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents,” Biochemical Pharmacology, vol. 60, no. 8, pp. 1051–1059, 2000. View at Publisher · View at Google Scholar
  10. J. Wesierska-Gadek, M. Gueorguieva, and M. Horky, “Dual action of cyclin-dependent kinase inhibitors: induction of cell cycle arrest and apoptosis. Acomparison of the effects exerted by roscovitine and cisplatin,” Polish Journal of Pharmacology, vol. 55, pp. 895–902, 2003. View at Google Scholar
  11. C. Swanton, “Cell-cycle targeted therapies,” The Lancet Oncology, vol. 5, no. 1, pp. 27–36, 2004. View at Publisher · View at Google Scholar
  12. M. Y. Yeh, D. Y. Yu, S. C. Chen et al., “Establishment and characterization of a human urinary bladder carcinoma cell line (TSGH-8301),” Journal of Surgical Oncology, vol. 37, no. 3, pp. 177–184, 1988. View at Google Scholar
  13. S. Samane, J. Noël, Z. Charrouf, H. Amarouch, and P. S. Haddad, “Insulin-sensitizing and anti-proliferative effects of Argania spinosa seed extracts,” Evidence-Based Complementary and Alternative Medicine, vol. 3, no. 3, pp. 317–327, 2006. View at Publisher · View at Google Scholar · View at PubMed
  14. E. Solary, S. Plenchette, O. Sordet et al., “Modulation of apoptotic pathways triggered by cytotoxic agents,” Therapie, vol. 56, no. 5, pp. 511–518, 2001. View at Google Scholar
  15. X. Liu, H. Zou, C. Slaughter, and X. Wang, “DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis,” Cell, vol. 89, no. 2, pp. 175–184, 1997. View at Google Scholar
  16. R. G. Panchal, “Novel therapeutic strategies to selectively kill cancer cells,” Biochemical Pharmacology, vol. 55, no. 3, pp. 247–252, 1998. View at Publisher · View at Google Scholar
  17. E. J. Park and J. M. Pezzuto, “Botanicals in cancer chemoprevention,” Cancer and Metastasis Reviews, vol. 21, no. 3-4, pp. 231–255, 2002. View at Publisher · View at Google Scholar
  18. D. L. Bemis, J. L. Capodice, J. E. Costello, G. C. Vorys, A. E. Katz, and R. Buttyan, “The use of herbal and over-the-counter dietary supplements for the prevention of prostate cancer,” Current Oncology Reports, vol. 8, pp. 228–236, 2006. View at Google Scholar
  19. M. J. Solomon, T. Lee, and M. W. Kirschner, “Role of phosphorylation in p34(cdc2) activation: identification of an activating kinase,” Molecular Biology of the Cell, vol. 3, no. 1, pp. 13–27, 1992. View at Google Scholar
  20. M. Tan, T. Jing, K.-H. Lan et al., “Phosphorylation on tyrosine-15 of p34Cdc2 by ErbB2 inhibits p34Cdc2 activation and is involved in resistance to taxol-induced apoptosis,” Molecular Cell, vol. 9, no. 5, pp. 993–1004, 2002. View at Publisher · View at Google Scholar
  21. D. E. Fisher, “Apoptosis in cancer therapy: crossing the threshold,” Cell, vol. 78, no. 4, pp. 539–542, 1994. View at Publisher · View at Google Scholar
  22. J. A. Hickman, “Apoptosis induced by anticancer drugs,” Cancer and Metastasis Reviews, vol. 11, no. 2, pp. 121–139, 1992. View at Google Scholar
  23. H. Zou, W. J. Henzel, X. Liu, A. Lutschg, and X. Wang, “Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3,” Cell, vol. 90, no. 3, pp. 405–413, 1997. View at Publisher · View at Google Scholar
  24. I. Budihardjo, H. Oliver, M. Lutter, X. Luo, and X. Wang, “Biochemical pathways of caspase activation during apoptosis,” Annual Review of Cell and Developmental Biology, vol. 15, pp. 269–290, 1999. View at Publisher · View at Google Scholar · View at PubMed
  25. R. M. Kluck, E. Bossy-Wetzel, D. R. Green, and D. D. Newmeyer, “The release of cytochrome c from mitochondria: a primary site for Bcl- 2 regulation of apoptosis,” Science, vol. 275, no. 5303, pp. 1132–1136, 1997. View at Publisher · View at Google Scholar
  26. F. H. Igney and P. H. Krammer, “Death and anti-death: tumour resistance to apoptosis,” Nature Reviews Cancer, vol. 2, no. 4, pp. 277–288, 2002. View at Google Scholar
  27. J. Lotem and L. Sachs, “Regulation by bcl-2, c-myc, and p53 of susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiation-competent and -defective myeloid leukemic cells,” Cell Growth & Differentiation, vol. 4, pp. 41–47, 1993. View at Google Scholar
  28. R. V. Talanian, C. Quinlan, S. Trautz et al., “Substrate specificities of caspase family proteases,” The Journal of Biological Chemistry, vol. 272, no. 15, pp. 9677–9682, 1997. View at Publisher · View at Google Scholar
  29. G. J. Hannon, “RNA interference,” Nature, vol. 418, no. 6894, pp. 244–251, 2002. View at Publisher · View at Google Scholar · View at PubMed